arBtrage CAPITALIZING MARKETS checking… Sign in

Armata Pharmaceuticals, Inc.

ARMP Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$7.50
▼ -2.5% Today
as of Jun 7, 07:09 ET
Last 30 days -23.16% Apr 28 → Jun 05
$7.30 $8.02 $8.74 $9.46 $10.18 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$7.73
High
$7.94
Low
$7.17
Volume
$35,880
Avg Vol
$100,416
Mkt Cap
$298M
P/E (TTM)
Beta
52w High
$16.34
52w Low
$1.74
Div Yield
Shares Out

Overview

52-week range
$1.74
$16
39% of range
Avg surprise (last 1)
+47.4%
Avg reaction (last 2)
-2.4%
0% positive
Latest IV / EM
248%
EM ±34.3% · $8 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.86$-0.68$-0.51$-0.33$-0.15 Actual $-0.17Actual $-0.86Actual $-0.69Actual $-0.25Actual $-0.15Actual $-0.20Est $-0.38Actual $-0.45Actual $-0.74Actual $-0.39 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-115M$-84M$-53M$-22M$9M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 13, 2026Mar/2026 $-0.39 -95.0% -2.0% earnings
Tue Sep 30, 2025Sep 2025 $-0.74 financials
Mon Jun 30, 2025Jun 2025 $-0.45 financials
Wed May 14, 2025Mar/2025 $-0.20 $-0.38 +47.4% -2.8% earnings
Mon Sep 30, 2024Sep 2024 $-0.15 financials
Sun Jun 30, 2024Jun 2024 $-0.25 financials
Sun Mar 31, 2024Mar 2024 $-0.69 financials
Sat Sep 30, 2023Sep 2023 $-0.86 financials
Fri Jun 30, 2023Jun 2023 $-0.17 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-9M$-8M$-7M$-8M$-10M$-12M
Net income$-115M$-27M$-16M$-7M$-5M$9M
EPS (diluted)$-3.16$-0.74$-0.45$-0.20$-0.15$-0.25

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$5M$9M$15M$4M$12M$9M$17M$26M
Inventory
Total current assets$6M$11M$17M$8M$13M$11M$22M$31M
Total assets$70M$77M$90M$81M$87M$86M$98M$108M
Long-term debt
Total liabilities$381M$295M$185M$150M$141M$134M$149M$154M
Total equity$-312M$-219M$-96M$-70M$-54M$-48M$-51M$-46M

Implied volatility — last 90 days

242%245%247%250%252% Jun 07 — IV 248% · EM ±34.3%

Sector peers